ArticleBMC geriatrics2025
Cross-cultural adaptation and validation of the Sinhala version of SarQoL
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSarcopenia, characterized by the loss of muscle strength, mass, and function, significantly impacts the quality of life (QoL) in older adults. The Sarcopenia Quality of Life (SarQoL
methodsThe standard protocol for cross-cultural adaptation was followed, including forward translation, synthesis, backward translation, expert committee review, and pre-testing. The finalized Sinhala version of SarQoL
resultsThe mean age of participants was 72.1 ± 4.8 years, with 139 (47.1%) identified as having probable sarcopenia. The questionnaire demonstrated strong internal consistency (Cronbach's alpha = 0.82) and excellent test-retest reliability (Intraclass Correlation Coefficient; ICC = 0.90; 95% CI: 0.81-0.96). Significant correlations between SarQoL
conclusionsThe Sinhala version of SarQoL
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.